Treating skin cancers with surgery is still the standard of care for most NMSC patients. However, surgery is not without potential downsides, especially for patients with other health issues. Surface radiotherapy, both Electronic Brachytherapy (EBT) and Superficial Radiation Therapy (SRT), is an FDA-approved treatment option and an excellent choice for select NMSC patients. Explore the case study below to see how Dr. Steven Davis has had success treating patients with surface radiation therapy.
Maui Derm Hawaii 2025 to Feature Xstrahl’s Dual Modality Treatment Solution for Dermatologists
Xstrahl, a global leader in the delivery of superficial radiation therapy devices and preclinical radiation research systems, will feature Radiant Aura at the Maui Derm Hawaii 2025 meeting, January 20-24, 2025. Radiant Aura is a low-dose, X-ray based, dual modality radiation therapy for treating non-melanoma skin cancers (NMSC) and keloid scarring.
